On Jan 27, 2022 First Dollar closed a Series A round and raised $14,000,000 from BlueCross BlueShield Venture Partners, Brian Gambs, Fay Rotenberg, Jonathan Bush, […]
Series A – MAYD
On Jan 27, 2022 MAYD closed a Series A round and raised €30,000,000 from 468 Capital, Earlybird Venture Capital, Lightspeed Venture Partners, Target Global, featuring […]
Series B – Leyden Labs
On Jan 25, 2022 Leyden Labs closed a Series B round and raised $140,000,000 from Bluebird Ventures, Brook Byers, Casdin Capital, F-Prime Capital, GV, Invus, […]
Series A – Cytovation
On Jan 25, 2022 Cytovation closed a Series A round and raised NOK180,000,000 from Canica, Project Sandwater, featuring lead investors Canica, Project Sandwater. About the […]
Series A – Cellino Biotech
On Jan 25, 2022 Cellino Biotech closed a Series A round and raised $80,000,000 from Leaps by Bayer, featuring lead investors Leaps by Bayer. About […]
Series B – Metagenomi
On Jan 25, 2022 Metagenomi closed a Series B round and raised $175,000,000 from Bristol Myers Squibb, Deep Track Capital, Eventide Asset Management, Farallon Capital […]
Series A – Resilience
On Jan 25, 2022 Resilience closed a Series A round and raised €40,000,000 from Cathay Innovation, Exor Seeds, Fondation Santé Service, MACSF, Picus Capital, Ramsay […]
Series A – Reimagine Care
On Jan 25, 2022 Reimagine Care closed a Series A round and raised $25,000,000 from City of Hope, LRVHealth, Martin Ventures, McKesson Ventures, Sable, Sante […]
Series A – Atlas Labs
On Jan 25, 2022 Atlas Labs closed a Series A round and raised $40,000,000 from Felicis Ventures, Global Founders Capital, GreatPoint Ventures, MBX Capital, Tribe […]
Series A – SeqOne Genomics
On Jan 24, 2022 SeqOne Genomics closed a Series A round and raised €20,000,000 from Elaia, IRDI, Merieux Equity Partners, Omnes Capital, featuring lead investors […]
